Loading...
EGFR Inhibition in the Treatment of Non-Small Cell Lung Cancer
Epidermal growth factor receptor (EGFR) inhibitors have introduced the concept of targeted therapy to the treatment of non-small cell lung cancer (NSCLC). These agents appear most effective in patients with tumors that are highly dependent on EGFR signaling pathways, a population that disproportiona...
Na minha lista:
| Hovedforfatter: | |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2008
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2701650/ https://ncbi.nlm.nih.gov/pubmed/19562083 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ddr.20268 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|